Daniel, let's talk about some of the tariffs that you identified as being the thing that really perhaps uh ch uh uh stimulated or stoked this about face in terms of investor sentiment. Now, with regards to say the H-1B visas on IT services and the pharmaceutical sector, we had a guest just about 10 minutes ago speak to us. They actually think that these were knee-jerk reactions because the H-1B visas will impact American tech companies more and the pharmaceutical companies because they're mostly in the gene ...